InsidersTradesSigma
Track the 한화생명 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Banks sector, 한화생명 has recorded 5 insider filings. Market capitalisation: €3,328.7bn. The latest transaction was filed on 30 June 2026 (Purchase). Among the most active insiders: 이종호. Every trade is free.
Analysts rate 한화생명 Hold (neutral), based on 13 analysts. Average price target: ₩5,200.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Hanwha Life is a South Korean insurance company that provides various life insurance products and financial services. It is listed on the Korea Exchange, XKRX.